The results demonstrate that treatment with HAP NPs, 3 h after middle cerebral artery occlusion (MCAO), significantly decreased stroke volume by 27% and 34% compared to free plasmin (Ctl-Plasmin) and nanoparticle controls (HA NP), respectively (Figure 7C). This evidence concerns the gene PLG and stroke disorder.